View Older Stories View More Recent Stories
-
Goldman Sachs to acquire Neos in $2.3B deal
-
SunEdison (SUNE) Misses Q2 EPS by 52c
-
3 E Network completes AI storage controller architecture spec
-
Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
-
Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
-
PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c
-
Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 39c
-
UPS issues $1B in senior notes, contributing $450M to pension trusts
-
Kornit Digital (KRNT) Tops Q2 EPS by 5c
-
Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
-
Nebius Group (NBIS) Q2 Revenue Tops Consensus
-
Gold Runner Exploration Appoints Justin Lowe as Senior Geologist and Manager of Exploration
-
Amarc Announces Geophysical Surveys Identifying Major New Sulphide Mineralized Systems Adjacent To The Aurora Porphyry Copper-Gold Discovery
-
GoGold Announces Q3 Financial Results
-
Acumen Pharmaceuticals, Inc. (ABOS) Misses Q2 EPS by 9c
-
Nebius Group revenue jumps 454% in Q2 2026 to $582.3M
-
TScan Therapeutics, Inc. (TCRX) Tops Q2 EPS by 3c
-
Madison Square Garden Entertainment (MSGE) Tops Q4 EPS by 37c
-
Altimmune, Inc. (ALT) Tops Q2 EPS by 3c
-
DataMeds AI unit reports $600K monthly revenue and new GLP-1 drugs
-
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
-
Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 46c
-
Replimune Group (REPL) Reiterated at Overweight by Cantor Fitzgerald
-
Local Bounti Corporation (LOCL) Misses Q2 EPS by 18c
-
MEMX seeks approval for binary options on corporate earnings
-
Unicycive Therapeutics, Inc (UNCY) Tops Q2 EPS by 42c
-
Exodus Movement (EXOD) PT Raised to $15 at Cantor Fitzgerald on Higher EV/Sales Multiple
-
Needham Reiterates Buy Rating on Lumentum (LITE)
-
BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
-
RETRANSMISSION: QIMC Reports Record 23.5% Natural Hydrogen Within the First 300 Metres of Ongoing DDH-26-05 and Observations Consistent with Free Gas at Bennett Hill at 164 Metres
-
eToro Group (ETOR) PT Lowered to $53 at Cantor Fitzgerald on Lower EBITDA Estimates
-
Aehr Test Systems receives $22M follow-on order for AI burn-in systems
-
Rekor adds audio verification to its GoSecure product
-
Ming Shing agrees to acquire Meals Through Seasons for $510M in stock
-
Platauro Metals Corp. Outlines Exploration and Development Strategy
-
Eastport Soil Geochemistry Results at Selebi-East Project Provide Multi-Kilometre Nickel-Copper Anomalies Tracking Prospective Amphibolite Host Rocks
-
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
-
SideChannel Reports FY 2026 Third Quarter Results
-
Kinross Gold Commences 2026 Drill Program at Riley Gold's PWC Gold Project (Cortez District - Nevada)
-
Aehr Receives $22 Million Follow-On Order for AI Processor Wafer-Level Burn-In Systems
-
Emerita Responds to Withhold Campaign and Urges Shareholders to Vote for All Six Director Nominees
-
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences (ACHV)
-
Shattuck Labs (STTK) PT Lowered to $14 at H.C. Wainwright
-
Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
-
Aura Biosciences (AURA) PT Lowered to $18 at H.C. Wainwright
-
Strive Enterprises, Inc. (ASST) PT Lowered to $36 at H.C. Wainwright
-
Alpha Tau Medical Ltd. (DRTS) PT Raised to $16 at H.C. Wainwright
-
Vera Therapeutics (VERA) PT Lowered to $90 at H.C. Wainwright
-
CoreWeave (CRWV) PT Raised to $178 at Cantor Fitzgerald Amid Strong Demand
-
Hemab Therapeutics Holdings (COAG) PT Raised to $60 at H.C. Wainwright
